XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - Other (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Nov. 30, 2022
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
May 31, 2024
Jan. 01, 2024
Stockholders' Equity              
Total compensation cost   $ 4,830 $ 4,006 $ 14,940 $ 11,638    
Maximum percentage of beneficial ownership for exercise of Pre-funded Warrants 9.99%            
Maximum percentage increase or decrease of beneficial ownership for exercise of Pre-funded Warrants 19.99%            
Threshold limit for giving prior notice 61 days            
Public Offering              
Stockholders' Equity              
Number of shares of common stock issued 12,421,053            
Proceeds from Issuance or Sale of Equity $ 64,500            
Number of pre-funded warrants (in shares) 2,105,264            
Research and development              
Stockholders' Equity              
Total compensation cost   1,353 1,519 4,629 4,329    
Selling, general and administrative              
Stockholders' Equity              
Total compensation cost   $ 3,477 $ 2,487 9,981 $ 7,309    
Restructuring costs              
Stockholders' Equity              
Total compensation cost       $ 330      
Series A Convertible Preferred Stock              
Shares              
Conversion of Series A Convertible Preferred Stock (in shares)   0 0 0      
Preferred stock, shares outstanding   0 4,300 0 4,300    
Number of common shares issuable upon conversion of stock     860,000   860,000    
Employee Stock Option              
Stock Options              
Outstanding (in shares)   8,423,068   8,423,068      
Outstanding, weighted-average exercise price (in dollars per share)   $ 8.94   $ 8.94      
Granted (in shares)       2,430,868      
Granted (in dollars per share)       $ 7.11      
Restricted Stock Units              
Stockholders' Equity              
Vesting period       3 years      
Shares              
Issued (in shares)       1,963,350      
Awards outstanding (in shares)   2,142,272   2,142,272      
2014 Plan              
Stockholders' Equity              
Common stock reserved for issuance (in shares)   0   0     3,090,220
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant             0
2014 Plan | Employee Stock Option              
Stock Options              
Outstanding (in shares)   5,916,369   5,916,369      
Granted (in shares)       1,540,519      
Equity Incentive Plan, Employee Inducements | Employee Stock Option              
Stock Options              
Outstanding (in shares)   1,768,122   1,768,122      
Granted (in shares)       123,975      
2024 Plan              
Stockholders' Equity              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant   3,885,857   3,885,857      
Stock Options              
Outstanding (in shares)   738,577   738,577      
2024 Plan | Maximum              
Stockholders' Equity              
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized           4,000,000  
2024 Plan | Employee Stock Option              
Stock Options              
Granted (in shares)       766,374